HIKMA PHARMACEUTICALS PLC revenue breakdown overview

HIKMA PHARMACEUTICALS PLC revenue for the last year amounted to 2.60 B EUR, the most of which — 1.12 B EUR — came from its highest performing source at the moment, Injectables, the year earlier bringing 1.05 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought HIKMA PHARMACEUTICALS PLC 1.60 B EUR, and the year before that — 1.31 B EUR.